Zobrazeno 1 - 10 of 243 pro vyhledávání: '"Dudreuilh C"'
1
Akademický článek
Activation and Regulation of Indirect Alloresponses in Transplanted Patients With Donor Specific Antibodies and Chronic Rejection.
Autor: Basu S; Centre for Nephrology, Urology and Transplantation, King's College London, London, United Kingdom.; Department of Inflammation Biology, King's College London, London, United Kingdom., Dudreuilh C; Centre for Nephrology, Urology and Transplantation, King's College London, London, United Kingdom.; Transplantation, Renal and Urology Directorate, Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, United Kingdom., Shah S; Centre for Nephrology, Urology and Transplantation, King's College London, London, United Kingdom.; Renal Unit, King's College Hospital NHS Foundation Trust, London, United Kingdom., Sanchez-Fueyo A; Department of Inflammation Biology, King's College London, London, United Kingdom.; Liver Sciences, King's College London, London, United Kingdom., Lombardi G; Centre for Nephrology, Urology and Transplantation, King's College London, London, United Kingdom.; Department of Inflammation Biology, King's College London, London, United Kingdom., Dorling A; Centre for Nephrology, Urology and Transplantation, King's College London, London, United Kingdom.; Department of Inflammation Biology, King's College London, London, United Kingdom.
Publikováno v: Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2024 Aug 20; Vol. 37, pp. 13196. Date of Electronic Publication: 2024 Aug 20 (Print Publication: 2024).
Zobrazit plný text záznamu
2
Akademický článek
Granulomatous Tubulointerstitial Nephritis in a Kidney Allograft: Treatment with Interleukin-6 Receptor Antagonist Stabilises Kidney Function.
Autor: Doctor GT; Department of Transplantation, Renal and Urology, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK., Dudreuilh C; Department of Transplantation, Renal and Urology, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK., Perera R; Department of Transplantation, Renal and Urology, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK., Dorling A; Department of Transplantation, Renal and Urology, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.
Publikováno v: Journal of clinical medicine [J Clin Med] 2024 Jun 11; Vol. 13 (12). Date of Electronic Publication: 2024 Jun 11.
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Highly sensitised individuals present a distinct Treg signature compared to unsensitised individuals on haemodialysis.
Autor: Dudreuilh C; Department of Inflammation Biology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.; Centre for Nephrology, Urology and Transplantation, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom., Basu S; Department of Inflammation Biology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.; Centre for Nephrology, Urology and Transplantation, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom., Shaw O; Synnovis Clinical Transplantation Laboratory, Guy's Hospital, London, United Kingdom., Burton H; Department of Inflammation Biology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.; Centre for Nephrology, Urology and Transplantation, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom., Mamode N; Department of Inflammation Biology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.; Centre for Nephrology, Urology and Transplantation, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom., Harris F; Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom., Tree T; Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom., Nedyalko P; NIHR Guy's and St Thomas' Biomedical Research Centre at Guy's and St Thomas NHS Foundation Trust, St Thomas' Hospital, London, United Kingdom., Terranova-Barberio M; NIHR Guy's and St Thomas' Biomedical Research Centre at Guy's and St Thomas NHS Foundation Trust, St Thomas' Hospital, London, United Kingdom., Lombardi G; Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom., Scottà C; Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom., Dorling A; Department of Inflammation Biology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.; Centre for Nephrology, Urology and Transplantation, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
Publikováno v: Frontiers in transplantation [Front Transplant] 2023 Oct 30; Vol. 2, pp. 1165320. Date of Electronic Publication: 2023 Oct 30 (Print Publication: 2023).
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy.
Autor: Morel A; Nephrology and Renal Transplantation Department, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France., Hoisnard L; AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Centre d'Investigation Clinique and Fédération Hospitalo-Universitaire TRUE (InnovaTive theRapy for immUne disordErs), Créteil, France.; Université Paris Est Créteil (UPEC), EpiDermE (Epidemiology in Dermatology and Evaluation of therapeutics), Créteil, France., Dudreuilh C; Nephrology and Renal Transplantation Department, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France., Moktefi A; Groupe Hospitalier Henri-Mondor/Albert-Chenevier, Pathology Department, AP-HP (Assistance Publique-Hôpitaux de Paris), Créteil, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), Université Paris-Est Créteil, Créteil, France., Kheav D; AP-HP (Assistance Publique-Hôpitaux de Paris), Laboratoire Régional d'histocompatibilité, Hôpital Saint Louis, Vellefaux, Paris., Pimentel A; Nephrology and Renal Transplantation Department, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France., Sakhi H; Nephrology and Renal Transplantation Department, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France., Mokrani D; Nephrology and Renal Transplantation Department, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France., Attias P; Nephrology and Renal Transplantation Department, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France., El Sakhawi K; Nephrology and Renal Transplantation Department, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France., Champy CM; Groupe Hospitalier Henri-Mondor/Albert Chenevier, Urology department, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France., Remy P; Nephrology and Renal Transplantation Department, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), Université Paris-Est Créteil, Créteil, France., Sbidian E; AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Centre d'Investigation Clinique and Fédération Hospitalo-Universitaire TRUE (InnovaTive theRapy for immUne disordErs), Créteil, France.; Université Paris Est Créteil (UPEC), EpiDermE (Epidemiology in Dermatology and Evaluation of therapeutics), Créteil, France.; Department of Dermatology, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France.; INSERM, Centre d'Investigation Clinique 1430, Créteil, France., Grimbert P; Nephrology and Renal Transplantation Department, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France.; AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Centre d'Investigation Clinique and Fédération Hospitalo-Universitaire TRUE (InnovaTive theRapy for immUne disordErs), Créteil, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), Université Paris-Est Créteil, Créteil, France.; AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, CIC biotherapy, Créteil, France., Matignon M; Nephrology and Renal Transplantation Department, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpitaux Universitaires Henri Mondor, Créteil, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) U955, Institut Mondor de Recherche Biomédicale (IMRB), Université Paris-Est Créteil, Créteil, France.
Publikováno v: Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2022 Apr 13; Vol. 35, pp. 10228. Date of Electronic Publication: 2022 Apr 13 (Print Publication: 2022).
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressive.
Autor: Mohseni YR; MRC Centre for Transplantation Immunology, School of Immunology and Microbial Sciences, King's College London, London, UK., Saleem A; MRC Centre for Transplantation Immunology, School of Immunology and Microbial Sciences, King's College London, London, UK.; Imaging Therapies and Cancer Group, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Studies, King's College London, London, UK.; Department of Haematology and Precision Medicine, Kings College Hospital, London, UK., Tung SL; MRC Centre for Transplantation Immunology, School of Immunology and Microbial Sciences, King's College London, London, UK., Dudreuilh C; MRC Centre for Transplantation Immunology, School of Immunology and Microbial Sciences, King's College London, London, UK., Lang C; Imaging Therapies and Cancer Group, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Studies, King's College London, London, UK., Peng Q; MRC Centre for Transplantation Immunology, School of Immunology and Microbial Sciences, King's College London, London, UK., Volpe A; Imaging Therapies and Cancer Group, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Studies, King's College London, London, UK., Adigbli G; Transplantation Research & Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Cross A; Transplantation Research & Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Hester J; Transplantation Research & Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Farzaneh F; Department of Haematological Medicine, School of Cancer and Pharmaceutical Studies, King's College London, London, UK., Scotta C; MRC Centre for Transplantation Immunology, School of Immunology and Microbial Sciences, King's College London, London, UK., Lechler RI; MRC Centre for Transplantation Immunology, School of Immunology and Microbial Sciences, King's College London, London, UK., Issa F; Transplantation Research & Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Fruhwirth GO; Imaging Therapies and Cancer Group, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Studies, King's College London, London, UK., Lombardi G; MRC Centre for Transplantation Immunology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Publikováno v: European journal of immunology [Eur J Immunol] 2021 Oct; Vol. 51 (10), pp. 2522-2530. Date of Electronic Publication: 2021 Aug 08.
Zobrazit plný text záznamu
10
Akademický článek
IgG SARS-CoV-2 Antibodies Persist at Least for 10 Months in Patients on Hemodialysis.
Autor: Dudreuilh C; Renal & Transplant Unit, Guy's and St. Thomas' NHS Foundation Trust, London, UK., Roper T; Renal & Transplant Unit, Guy's and St. Thomas' NHS Foundation Trust, London, UK., Breen C; Renal & Transplant Unit, Guy's and St. Thomas' NHS Foundation Trust, London, UK., Chowdhury P; Renal & Transplant Unit, Guy's and St. Thomas' NHS Foundation Trust, London, UK., Douthwaite S; Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, London, UK., Kumar N; Renal & Transplant Unit, Guy's and St. Thomas' NHS Foundation Trust, London, UK., Moutzouris DA; Renal & Transplant Unit, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Publikováno v: Kidney international reports [Kidney Int Rep] 2021 Jul; Vol. 6 (7), pp. 1961-1964. Date of Electronic Publication: 2021 Apr 08.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje